{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:14:08Z","timestamp":1783710848856,"version":"3.55.0"},"reference-count":29,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,23]]},"DOI":"10.14218\/jcth.2021.00058","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T05:58:34Z","timestamp":1619157514000},"page":"000-000","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease"],"prefix":"10.14218","volume":"000","author":[{"given":"Yi-Wen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qiang","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Sheng","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Dan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Gao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"issue":"1","key":"key20210423055815_JCTH-D-21-00058-b1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"key20210423055815_JCTH-D-21-00058-b3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The Association between nonalcoholic fatty liver disease and metabolic abnormalities in the United States population","volume":"51","author":"Jinjuvadia","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"key20210423055815_JCTH-D-21-00058-b4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.14401","article-title":"Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease","volume":"47","author":"Sookoian","year":"2018","journal-title":"Aliment PharmacolTher"},{"key":"key20210423055815_JCTH-D-21-00058-b5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.diabet.2017.02.007","article-title":"Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease","volume":"43","author":"Gutierrez-Grobe","year":"2017","journal-title":"Diabetes Metab"},{"key":"key20210423055815_JCTH-D-21-00058-b6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"key20210423055815_JCTH-D-21-00058-b7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"key20210423055815_JCTH-D-21-00058-b9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO).EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"","year":"2016","journal-title":"J Hepatol"},{"key":"key20210423055815_JCTH-D-21-00058-b10","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s12325-016-0416-4","article-title":"Evaluating the relationship between metabolic syndrome and liver biopsy-proven non-alcoholic steatohepatitis in China: a multicenter cross-sectional study design","volume":"33","author":"Xu","year":"2016","journal-title":"Adv Ther"},{"issue":"17","key":"key20210423055815_JCTH-D-21-00058-b11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"key20210423055815_JCTH-D-21-00058-b12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b13","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"key20210423055815_JCTH-D-21-00058-b15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"key20210423055815_JCTH-D-21-00058-b16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"issue":"5","key":"key20210423055815_JCTH-D-21-00058-b17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","article-title":"Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals","volume":"70","author":"Mantovani","year":"2021","journal-title":"Gut"},{"key":"key20210423055815_JCTH-D-21-00058-b18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","author":"Chitturi","year":"2002","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b19","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/liv.13739","article-title":"Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease","volume":"38","author":"Bertot","year":"2018","journal-title":"Liver Int"},{"key":"key20210423055815_JCTH-D-21-00058-b20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12020-020-02268-7","article-title":"Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and mediterranean diet pattern as a protective factor","volume":"68","author":"Aller","year":"2020","journal-title":"Endocrine"},{"key":"key20210423055815_JCTH-D-21-00058-b21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.1840190312","article-title":"Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis","volume":"19","author":"Petrides","year":"1994","journal-title":"Hepatology"},{"key":"key20210423055815_JCTH-D-21-00058-b22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"key":"key20210423055815_JCTH-D-21-00058-b23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.23736\/S0026-4806.19.05978-0","article-title":"Older age and HDL-cholesterol as independent predictors of liver fibrosis assessed by BARD score","volume":"110","author":"Klisic","year":"2019","journal-title":"Minerva Med"},{"key":"key20210423055815_JCTH-D-21-00058-b24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab"},{"key":"key20210423055815_JCTH-D-21-00058-b25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia"},{"key":"key20210423055815_JCTH-D-21-00058-b26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.14219","article-title":"Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD","volume":"46","author":"Petta","year":"2017","journal-title":"Aliment PharmacolTher"},{"key":"key20210423055815_JCTH-D-21-00058-b27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","article-title":"Role of imaging-based biomarkers in NAFLD: recent advances in clinical application and future research directions","volume":"68","author":"Loomba","year":"2018","journal-title":"J Hepatol"},{"key":"key20210423055815_JCTH-D-21-00058-b28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"key20210423055815_JCTH-D-21-00058-b29","doi-asserted-by":"crossref","DOI":"10.1038\/s41575-021-00433-5","article-title":"What are the clinical settings and outcomes of lean NAFLD?","author":"Ren","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:51Z","timestamp":1783707591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":29,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,4,23]]},"published-print":{"date-parts":[[2021,4,23]]}},"alternative-id":["10.14218\/JCTH.2021.00058"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00058","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]}}}